Corebridge Financial’s SWOT analysis: insurance giant’s stock faces growth hurdles

Corebridge Financial (CRBG), a North American insurance and life sector player, presents a mixed investment profile, balancing strong free cash flow generation—projected at $1.9 billion for 2025—and ambitious long-term core EPS growth targets of 10-15% annually. However, the company faces near-term headwinds, including downward revisions to 2025/2026 EPS estimates by analysts, notably BMO Capital Markets, primarily due to anticipated spread income compression in its Individual Retirement segment, which is expected to limit 2025 core EPS growth to less than 10%. Despite these challenges and recent negative basic EPS, analysts generally maintain a positive long-term outlook with potential upside of up to 28% to current price targets, balancing robust cash generation against competitive and regulatory risks.

Analysis

Corebridge Financial (CRBG) presents a bifurcated investment profile, balancing significant near-term profitability headwinds against a robust long-term outlook supported by strong cash generation. The primary concern is spread income compression, particularly within the Individual Retirement segment, which has prompted analysts like BMO Capital Markets to revise 2025 and 2026 EPS estimates downward by 5% and 8%, respectively. Management acknowledges this pressure, guiding for core EPS growth of less than 10% in 2025, a figure below its ambitious long-term annual target of 10-15%. This is compounded by a weak gross profit margin of 21.82% and negative basic EPS of -$0.60 over the last twelve months. Conversely, the company's financial strength is evident in its projected net free cash flow of approximately $1.9 billion for 2025, which represents about 67% of GAAP operating earnings. This cash flow underpins a solid capital return strategy, including management share buybacks and guided 5-10% growth in subsidiary dividends for 2025. Despite near-term estimate cuts, analyst price targets ranging from $37 to $46 imply a potential upside of up to 28%, suggesting a consensus that CRBG can navigate current challenges and leverage its financial strength for future growth.

Key Decisions for Investors

• Long-term investors could consider the current valuation an opportunity, focusing on the projected $1.9 billion in 2025 free cash flow and 10-15% long-term EPS growth targets, provided they can tolerate near-term volatility from margin pressures.
• It is critical to monitor quarterly performance for any stabilization in spread income, as this is the primary headwind impacting the company's ability to meet its sub-10% core EPS growth guidance for 2025.
• Evaluate management's capital allocation effectiveness, as the ability to deploy strong free cash flow to offset margin pressures and execute on strategic moves like the recent VA transaction is key to realizing the potential upside implied by analyst targets.
• Given the downward revisions to earnings estimates, investors should weigh whether the potential 28% upside adequately compensates for the execution risk associated with near-term profitability challenges in a competitive market.